Lakefront Biotherapeutics reported EUR13.56M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
argenx SE USD 44.87M 2.17M Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Biogen USD 37.9M 700K Mar/2026
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Incyte USD 33.69M 2.93M Mar/2026
Merck EUR 21M 6M Dec/2025
Sanofi EUR 33M 81M Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026